RESUMO
Relata-se o caso de paciente feminina, 22 anos, sem história médica prévia relevante, admitida no Serviço de Urgência por cansaço progressivo e dor precordial aguda, referindo queixa abdominais há 72 horas. Avaliação médica revela presença de derrame pericárdio moderado. Internada, evolui em tamponamento cardíaco, requerendo pericardiocentese. É determinada a presença de Salmonella enteritidis no líquido pericárdico, e então iniciado tratamento com antibiótico. O prognóstico foi satisfatório, com recuperação total clínica e ecocardiográfica.
Report on a 22 year old female with no relevant prior medical history who was admitted to the Ermergency Department complaining of acute chest pain and progressive fadigue, mentioning abdominal complaints 72 hours previously. A medical evaluation showed moderate pericardial effusion. After admission, this developed into pericardial tamponade, requiring pericardiocentecis. Salmonella enteriditis was identified in the pericardial fluid, starting treatment with antibiotics. The prognosis was satisfactory , with complete clinical and echocardiographic recovery.
Assuntos
Humanos , Feminino , Adulto , Pericardite/complicações , Pericardite/diagnóstico , Salmonella enteritidis , Tamponamento Cardíaco/complicações , Ecocardiografia/métodos , Ecocardiografia , Radiografia Torácica/métodos , Radiografia TorácicaRESUMO
Fundamentos: O diabetes mellitus (DM) é reconhecidamente fator de risco cardiovascular. Sabendo-se que a intervenção coronariana percutânea (ICP) melhora o prognóstico da doença coronariana (DC), pretendemos verificar se esse efeito é similar em doentes diabéticos (D) e não diabéticos (ND). Objetivo: Analisar o prognóstico em longo prazo do DM em pacientes submetidos a ICP. Métodos: Estudo de coorte, unicêntrico, retrospectivo, envolvendo pacientes consecutivos submetidos à ICP, eletiva ou de urgência, entre janeiro 2002 e dezembro 2003. Definiram-se dois grupos: pacientes com DM (D) e sem DM (ND). compararam-se as variáveis clínicas e angiográficas da ICP com resultado clínico ao final de cinco anos. Definiram-se como eventos maiores cardiovasculares (EMC): morte, nova síndrome coronariana aguda, acidente vascular encefálico (AVE) e nova revascularização cirúrgica ou ICP. Foram ainda avaliadas as taxas de trombose de stent, revascularização do vaso-alvo (RVA) e revascularização da lesão-alvo (RLA). Resultados: O seguimento em cinco anos foi 94%. Foram realizadas 446 ICP em 406 pacientes, média de idade=63,0+-11 anos, 70,4% masculino. Destes, 128 (31,5%) eram do grupo D. Em cinco anos o valor de EMC foi 50,7% para D e 36,7% para N. Encontrou-se mortalidade global...
Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Angioplastia/métodos , Angioplastia , Diabetes Mellitus/diagnóstico , Doença das Coronárias/complicações , Doença das Coronárias/diagnóstico , Fatores de Risco , Estudos de Coortes , PrognósticoRESUMO
INTRODUCTION: Recent genome-wide association studies have identified single-nucleotide polymorphisms (SNPs) at the 9p21 locus as risk factors for coronary artery disease (CAD). Among them, the SNP rs1333049 has demonstrated a consistent association with CAD, which has been successfully replicated in several populations. AIM: To investigate whether the SNP rs1333049 located on the 9p21 chromosome is an independent risk factor for CAD in a Portuguese population. METHODS: We performed a case-control study which included 1406 individuals, 723 consecutive coronary patients (mean age 53.71 +/- 8.9 years, 79.9% male and 683 controls without coronary disease (mean age 53.3 +/- 10.5 years, 73.9% male). Cases and controls were selected so as not to be significantly different in terms of gender and age. We studied the SNP rs1333049 at the 9p21 locus in all individuals, using standard PCR combined with the TaqMan technique (Applied Biosystems). The allelic and genotype distribution (C/G), odds ratios and corresponding confidence intervals for CAD risk were determined. A forward Wald logistic regression analysis model was constructed, adjusted for age, gender, conventional risk factors, biochemical markers and the genotypes under study, in order to determine which variables were linked significantly and independently with CAD. RESULTS: The C allele was found in 60% of the CAD patients and 53% of the controls, with OR = 1.33; p = 0.0002. The CC genotype appeared in 35.7% of CAD patients, with OR = 1.34, p = 0.010. The heterozygous CG genotype was present in 48.1% of the CAD patients and 47% of the controls, and did not present vascular risk (OR = 1.05, p = 0.670). After logistic regression analysis, the CC genotype remained in the equation with OR = 1.7; p = 0.018 and CG with OR = 1.5, p = 0.048. CONCLUSION: In the present study we replicated the coronary risk linked to the recently discovered variant rs1333049 on the 9p21 chromosome in a Portuguese population. Although the mechanism underlying the risk is still unknown, the robustness of this risk allele in risk stratification for CAD has been consistent, even in very different populations. The presence of the CC or CG genotype may thus prove to be useful for predicting the risk of developing CAD in the Portuguese population.
Assuntos
Doença das Coronárias/genética , Polimorfismo de Nucleotídeo Único , Estudos de Casos e Controles , Cromossomos Humanos Par 9/genética , Feminino , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
Mulher de 58 anos, sem antecedentes médicos relevantes, apresenta infecção respiratória pelo vírus H1N1, requerendo internação na Unidade de Cuidados Intensivos. Após a alta, refere progressiva astenia e dispneia, sendo internada nove meses depois por derrame pleural e infecção respiratória. Avaliação específica pela Cardiologia revela cardiomiopatia dilatada com má função sistólica do ventrículo esquerdo, compatível com miocardite. A ressonância magnética se apresenta compatível com miocardite. Dados os antecedentes e havendo sido descartada doença autoimune e tóxica, associou-se a doença ao vírus H1N1. O prognóstico é muito positivo, com recuperação quase total da função do ventrículo esquerdo.
A 58-year-old woman with no relevant prior medical conditions presented a respiratory infection caused by theH1N1 virus, requiring admittance to an Intensive Care Unit. After discharge, the patient complained of progressiveasthenia and dyspnea, being hospitalized nine months later with a diagnosis of pleural effusion and respiratory infection. Further evaluation by the Cardiology Unit revealed dilated cardiomyopathy with poor systolicfunction of the left ventrícle, compatible with myocarditis. A cardiac magnetic ressonance examination was compatible with myocarditis. Given her previousadmittance and having ruled out toxic aspects and autoimmune disease, the disease was associated with the H1N1 virus. The prognosis is very positive, with almost complete recovery of the left ventricular function.
Assuntos
Humanos , Feminino , Idoso , Cardiomiopatia Dilatada/complicações , Cardiomiopatia Dilatada/diagnóstico , Disfunção Ventricular Esquerda/complicações , Disfunção Ventricular Esquerda/diagnóstico , Vírus da Influenza A Subtipo H1N1 , Miocardite/complicações , Miocardite/diagnósticoRESUMO
INTRODUCTION: Coronary artery disease (CAD) is the main cause of mortality in developed countries. Increased lipid peroxidation is associated with accelerated progression of atherosclerosis. Paraoxonase (PON1) is an antioxidant enzyme bound to high-density lipoprotein (HDL), which protects against lipid peroxidation and coronary artery disease. PON1 activity is under genetic control and its molecular basis is a polymorphism in the PON1 gene that shows two common isoforms: the wild Q form (192 Gln) with high ability to protect LDL from lipid peroxidation in vitro, and the mutated R (Arg) form with lower ability. AIM: To explore the interaction of the R allele of the paraoxonase gene and low HDL-cholesterol concentrations in CAD risk. METHODS: The study population consisted of 818 individuals, 298 coronary patients, aged 55.0 +/- 10.3 years, 78.9% male, and 520 age and gender matched healthy controls, aged 53.3 +/- 11.7 years, 72.5% male. Low HDL-cholesterol was defined as < 0.90 mmol/l in men and < 1.11 mmol/l in women. Comparisons of genotypes between cases and controls were performed by a chi-square test. Statistical significance was accepted at p < 0.05. Odds ratios and 95% confidence intervals for the RR genotypes and HDL-deficient subjects were computed using univariate analysis (2 x 2 tables). To determine the interaction between the RR paraoxonase genotype and HDL-deficient subjects, we used 4 x 2 epidemiologic tables and synergy measures: the additive model (Rothman's synergy index, SI) and multiplicative model (Khoury's synergy index, SIM). The relative excess risk due to interaction (RERI) and the attributable proportion (AP) due to interaction (Rothman) were calculated. RESULTS: The PON1 RR192 polymorphism was associated with coronary heart disease (OR = 1.61; p = 0.043) in the whole population. HDL-deficient subjects with the RR192 genotype showed increased risk for CAD (OR = 17.38; p < 0.0001) compared to those with normal HDL and RR192 (OR = 1.39; p = 0.348) and HDL-deficient subjects not carrying the RR genotype (OR = 7.79; p < 0.0001). Synergy measures were SI = 2.3, SIM = 1.6; RERI = 9.2. CONCLUSION: These data suggest the existence of a synergistic effect of the PON1 RR192 genotype (with lower antioxidant ability) and HDL-deficient subjects in risk for development of CAD. The AP due to this interaction was 0.53, meaning that 53% of CAD was explained by this interaction.
Assuntos
Arildialquilfosfatase/sangue , Arildialquilfosfatase/genética , HDL-Colesterol/sangue , Polimorfismo Genético , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de RiscoRESUMO
INTRODUCTION: Various studies have compared coronary artery disease (CAD) patients with controls in order to determine which polymorphisms are associated with a higher risk of disease. The results have often been contradictory. Moreover, these studies evaluated polymorphisms in isolation and not in association, which is the way they occur in nature. OBJECTIVE: Our purpose was to evaluate the risk of CAD in patients with associated polymorphisms in the same gene or in differen genes. METHODS: We evaluated the risk associated with ACE DD, ACE 8 CC, ACT 174MM, AGT 235TT, MTHFR 677TT, MTHFR 1298AA, PON1 192RR and PON1 55MM in 298 CAD patients and 298 healthy individuals. We then evaluated the risk of associated polymorphisms in the same gene (ACE DD + ACE 8GG; AGT 174MM + AGT 235TT; MTHFR 677TT + MTHFR 1298AA). Finally, for the isolated polymorphisms which were significant, we evaluated the risk of polymorphism associations at different functional levels (ACE + AGT; ACE + MTHFR; ACE + PON1). Multiple logistic regression was used to identify independent risk factors for CAD. RESULTS: Isolated polymorphisms including ACE DD(p < 0.0001), ACE 8 gg (p=0.023), and MTHFR 1298AA (p = 0.049) presented with a significantly higher frequency in the CAD group. An association of polymorphisms in the same gene did not have an additive or synergistic effect, nor did it increase the risk of CAD. Polymorphic associations in different genes increased the risk of CAD, compared with the isolated polymorphisms. The association of ACE DD or ACE 8 GG with PON1 192RR increased the risk of CA fourfold (1.8 to 4.2). After logistic regression analysis, current smoking, family history, fibrinogen, diabetes, and the ACE DD or ACE 8 GG + MTHFR 1298AA and ACE DD or ACE 8 GG + PON1 192RR associations remained in the, model and proved to be independent predictors of CAD. CONCLUSIONS: The association of polymorphisms in the same gene did not increase the risk of the isolated polymorphism. The association of polymorphisms in genes belonging to different enzyme systems was always linked to increased risk compared to the isolated polymorphisms. This study may contribute to a better understanding of overall genetic risk for CAD rather than that associated with each polymorphism in isolation.